NDAINTRAMUSCULARINJECTABLE
Approved
Jun 2001
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
4
Data completeness
3/8 — Basic
Drug data last refreshed 13h ago · AI intelligence enriched 1w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
TRELSTAR (triptorelin pamoate) is a GnRH agonist administered as an intramuscular injection used to treat advanced prostate cancer and other hormone-responsive conditions. It works by suppressing luteinizing hormone and follicle-stimulating hormone, reducing testosterone levels to castration levels. The drug has been on the market since 2001 and represents a well-established standard of care in oncology.
$14.0MPart D
LOE ApproachingThe product is approaching loss of exclusivity with modest Medicare spending, signaling a mature franchise with limited growth runway and likely streamlined team operations.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Clinical Trials (4)
Effects of Triptorelin Pamoate 6-month When Given to Adult Chinese Participants With Advanced Cancer in the Prostate
Started Nov 2022
195 enrolled
Advanced Prostate CancerMetastatic Prostate CancerLocally Advanced Prostate Cancer
Study to Compare the Oestradiol Suppression, Clinical Efficacy and Safety of Two Formulations of Triptorelin (Triptorelin Pamoate PR 3-month and Triptorelin Acetate PR 1-month) in Chinese Subjects With Endometriosis
Started Jul 2017
300 enrolled
Endometriosis
Induction and Maintenance of Castration After Subcutaneous Injections of Triptorelin Pamoate in Patients With Prostate Cancer
Started Jan 2013
126 enrolled
Prostate Cancer
Effects of Triptorelin Pamoate in Children With Precocious Puberty - Follow up Study
Started Apr 2008
35 enrolled
Precocious Puberty
Worked on TRELSTAR at Verity Pharmaceuticals? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.